Manta
Device
Essential Medical, Inc.
Total Payments
$832,776
Transactions
342
Doctors
239
Companies
5
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $4,541 | 157 | 142 |
| 2019 | $18,414 | 148 | 108 |
| 2018 | $809,822 | 37 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $820,544 | 38 | 98.5% |
| Food and Beverage | $12,232 | 304 | 1.5% |
Payments by Type
Research
$820,544
38 transactions
General
$12,232
304 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Pivotal Clinical Study to Evaluate the Safety and Effectiveness of MANTA Vascular Closure Device (MANTA) | Essential Medical, Inc. | $820,544 | 0 |
Top Doctors Receiving Payments for Manta
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Harrisburg, PA | $820,544 | 38 |
| , D.O | Cardiovascular Disease | Richmond Hill, NY | $423.41 | 5 |
| , MD | Cardiovascular Disease | Manhasset, NY | $405.80 | 5 |
| , M.D | Interventional Cardiology | Sacramento, CA | $337.39 | 4 |
| , MD | Interventional Cardiology | Houston, TX | $319.60 | 16 |
| , MD | Interventional Cardiology | Birmingham, AL | $280.41 | 2 |
| , M.D | Cardiovascular Disease | New York, NY | $278.71 | 3 |
| , MD | Cardiovascular Disease | Bronx, NY | $235.95 | 4 |
| , M.D | Interventional Cardiology | Manhasset, NY | $214.22 | 2 |
| , M.D | Orthopaedic Surgery | Lawrenceburg, TN | $211.29 | 1 |
| , M.D | Internal Medicine | Chicago, IL | $204.49 | 7 |
| , M.D | Interventional Cardiology | Round Rock, TX | $192.92 | 4 |
| , MD | Internal Medicine | Boston, MA | $185.69 | 2 |
| , MD | Interventional Cardiology | Detroit, MI | $181.18 | 2 |
| , MD | Interventional Cardiology | Bronx, NY | $169.85 | 1 |
| , MD | Interventional Cardiology | Kansas City, MO | $158.35 | 2 |
| , MD | Cardiovascular Disease | Tucson, AZ | $152.86 | 1 |
| , MD | Interventional Cardiology | Miami, FL | $149.88 | 2 |
| , M.D | Cardiovascular Disease | Seattle, WA | $144.85 | 1 |
| , M.D | Cardiovascular Disease | Suffern, NY | $144.85 | 1 |
| , MD | Cardiovascular Disease | New York, NY | $144.85 | 1 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Kansas City, MO | $144.35 | 1 |
| , MD | Interventional Cardiology | Kansas City, MO | $144.35 | 1 |
| , M.D | Cardiovascular Disease | West Hollywood, CA | $141.61 | 2 |
| , M.D | Interventional Cardiology | Marion, IL | $141.61 | 2 |
Ad
Manufacturing Companies
- Essential Medical, Inc. $820,544
- Teleflex LLC $8,529
- Arrow International, Inc. $3,320
- Teleflex Medical Incorporated $211.29
- Teleflex Incorporated $171.25
Product Information
- Type Device
- Total Payments $832,776
- Total Doctors 239
- Transactions 342
About Manta
Manta is a device associated with $832,776 in payments to 239 healthcare providers, recorded across 342 transactions in the CMS Open Payments database. The primary manufacturer is Essential Medical, Inc..
Payment data is available from 2018 to 2020. In 2020, $4,541 was paid across 157 transactions to 142 doctors.
The most common payment nature for Manta is "Unspecified" ($820,544, 98.5% of total).
Manta is associated with 1 research study, including "Pivotal Clinical Study to Evaluate the Safety and Effectiveness of MANTA Vascular Closure Device (MANTA)" ($820,544).